Tserio News News feeds from the largest sources

Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
Coherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Inc's infection-fighting treatment, Neulasta, at a 33 percent discount.
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount